Institut de Recherche pour le Développement, UMR216 Mère et enfant face aux infections tropicales.
J Infect Dis. 2013 Dec 15;208(12):1987-97. doi: 10.1093/infdis/jit377. Epub 2013 Jul 30.
Plasmodium falciparum is responsible for severe malaria, including pregnancy-associated malaria (PAM). During intra-erythrocytic maturation, the infected erythrocyte (iE) membrane is modified by insertion of parasite-derived proteins, primarily consisting of variant surface antigens such as P. falciparum erythrocyte membrane protein-1.
To identify new PAM-specific parasite membrane proteins, we conducted a mass spectrometry-based proteomic study and compared the protein expression profiles of 10 PAM and 10 uncomplicated malaria (UM) samples.
We focused on the 454/1139 membrane-associated and hypothetical proteins for comparative analysis. Using filter-based feature-selection methods combined with supervised data analysis, we identified a subset of 53 proteins that distinguished PAM and UM samples. Up to 19/20 samples were correctly assigned to their respective clinical group. A hierarchical clustering analysis of these 53 proteins based on the similarity of their expression profiles revealed 2 main clusters of 40 and 13 proteins that were under- or over-expressed, respectively, in PAM.
VAR2CSA is identified and associated with PAM, validating our experimental approach. Other PAM-predictive proteins included PFI1785w, PF14_0018, PFB0115w, PFF0325c, and PFA_0410w. These proteomics data demonstrate the involvement of selected proteins in the pathophysiology of PAM, providing new insights for the definition of potential new targets for a vaccine against PAM.
恶性疟原虫(Plasmodium falciparum)可导致严重疟疾,包括妊娠相关疟疾(pregnancy-associated malaria,PAM)。在红细胞内成熟过程中,受感染的红细胞(infected erythrocyte,iE)膜被插入寄生虫来源的蛋白所修饰,这些蛋白主要由变异表面抗原组成,如恶性疟原虫红细胞膜蛋白 1(P. falciparum erythrocyte membrane protein-1)。
为了鉴定新的 PAM 特异性寄生虫膜蛋白,我们进行了基于质谱的蛋白质组学研究,并比较了 10 例 PAM 和 10 例无并发症疟疾(uncomplicated malaria,UM)样本的蛋白表达谱。
我们专注于 454/1139 个膜相关和假定蛋白进行比较分析。使用基于滤器的特征选择方法结合有监督数据分析,我们鉴定出了一组 53 个能够区分 PAM 和 UM 样本的蛋白。多达 19/20 的样本被正确地分配到各自的临床组。对这 53 个蛋白的表达谱进行相似性层次聚类分析,发现了 2 个主要的聚类,分别包含 40 个和 13 个蛋白,它们在 PAM 中分别表达下调和上调。
VAR2CSA 被鉴定并与 PAM 相关,验证了我们的实验方法。其他与 PAM 相关的预测蛋白包括 PFI1785w、PF14_0018、PFB0115w、PFF0325c 和 PFA_0410w。这些蛋白质组学数据表明,选定蛋白参与了 PAM 的病理生理学,为定义 PAM 疫苗的潜在新靶点提供了新的见解。